首页|Centre Hospitalier Regional Reports Findings in Robotics (Pain outcomes of outsi de-the-cage robotic thoracic surgery: a prospective matched-cohort study)
Centre Hospitalier Regional Reports Findings in Robotics (Pain outcomes of outsi de-the-cage robotic thoracic surgery: a prospective matched-cohort study)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
New research on Robotics is the subjec t of a report. According to news reporting out of Nancy, France, by NewsRx edito rs, research stated, "Management of acute and chronic pain after thoracic surger y for pulmonary resection or thymectomy remains a challenge for both thoracic su rgeons and anesthesiologists. Advances in minimally invasive robotic procedures have made subcostal outside-the-cage (OTC) resections possible, but the procedur e's pain benefits have not been previously measured." Our news journalists obtained a quote from the research from Centre Hospitalier Regional, "A singlecenter cohort was consented to undergo robotic-assisted thor acoscopic surgery (RATS) with an OTC or transthoracic (TT) approach. On every po st-operative day (POD), patients were asked to complete the visual analog scale (VAS) of pain, assigning a score of 0-10 with higher scores equaling higher pain intensity. Additionally, patients' opioid consumption was recorded and classifi ed using morphine equivalent dose (MED). Descriptive statistics of demographics, Mann-Whitney, and Chi-squared tests were performed in a matched analysis. Altog ether, 50 OTC patients and 50 TT patients were included. For each group, 1 pneum onectomy, 19 lobectomies, 10 segmentectomies, and 20 thymectomies were performed . Between groups, most were male (n = 54; p = 0.42) and there were no difference s in American Society of Anesthesiologists scores (p = 0.51), or tobacco consump tion (p = 0.45). Patients who received an OTC approach experienced significantly lower pain scores on POD-0 (p = 0.001), POD-1 (p <0.001), and POD-2 (p <0.001). POD-3 OTC VAS scores were not diffe rent from those of the TT group (p = 0.09). Similarly, MED was lower for the OTC group on POD-0 (p <0.001), POD-1 (p = 0.03), and POD-3 (p = 0.03)."
NancyFranceEuropeEmerging Technolo giesHealth and MedicineMachine LearningRoboticsRobotsSurgery